AMERICAN GENE TECHNOLOGIES CEO JEFF GALVIN JOINS MARYLAND TECH COUNCIL BOARD OF DIRECTORS

ROCKVILLE, MD, UNITED STATES, August 20, 2018 /EINPresswire.com/ — American Gene Technologies International Inc. (AGT)’s CEO and founder Jeff Galvin has been appointed to the Board of Directors of the Maryland Tech Council, the largest Maryland technology trade association, representing over 600 companies across the breadth of technology and life science industries.

Galvin stated: “I am honored to contribute to the tremendous impact Maryland Tech Council is making in the state. It is an important enabler for biotech and technology — two industries that have huge potential economic impact for the state. It’s been a great experience to be a member for these past years, the Maryland Tech Council has made a positive impact on AGT. I see this appointment as an opportunity to give back to the important work Tami Howie and her team are doing to help build strong technology and life science companies in Maryland."

Galvin earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies.

Galvin is a veteran member of the Maryland Tech Council and has been involved in its recent progress. He participated in various activities with the Maryland Tech Council, including: jointly testifying before the Maryland Senate Finance Committee against generic drug price control legislation that could curtail Marylander’s access to drugs (SB1023); participating as a featured member at Maryland Tech Council's BIO International Conference; and sponsoring or participating in its other events, such as TEDCO’s Innovation Challenge, MTC Industry Awards, East Coast VentureCON, and the Bio+Tech18 Conference.

Tami Howie, CEO of Maryland Tech Council, announced: “As a 12-year veteran in the biotech industry in Maryland having decades of experience in Silicon Valley in the tech industry, we are excited to have Jeff Galvin join our Board of Directors. His strong experience and success in both tech and biotech will be instrumental to the work we do to foster a healthy biotech and technology ecosystem in Maryland. His mission and experience are closely linked to what we are creating in Maryland and we see his participation as an asset for the Council.”

Howie is a key opinion leader in Maryland’s biotech and technology industries. For the past 20 years, Howie has helped technology companies grow in the Mid-Atlantic region and nationwide. She has been involved with the successful exits of over 150 companies and has represented technology companies, investors, SBICs and underwriters such as JP Morgan, Goldman Sachs and Morgan Stanley. Howie and Galvin share a common passion for developing the tremendous potential of the biotechnology and technology industries in Maryland to dramatically increase the economy and business ecosystem. Maryland Tech Council published the following press release announcing 2018 appointments to the board: http://bit.ly/2OK3zsC

About American Gene Technologies (AGT):

AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious diseases, immune-oncology, and monogenic disorders. AGT expects to take its patented, lead candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Four key patents in AGT’s novel immuno-oncology approach have been granted. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.

Website: https://www.americangene.com/

American Gene Technologies Contact:

C. Neil Lyons, Chief Financial Officer
Phone: (301) 337-2269
Email: info@americangene.com

Company Social Media:

LinkedIn – https://www.linkedin.com/company/american-gene-technologies-international-inc/
Twitter – @americangene, https://twitter.com/americangene
Facebook – @amerigene, https://www.facebook.com/amerigene/
Instagram – @americangenetechnologies, https://www.instagram.com/americangenetechnologies/

Media Contact: Sasha Whitaker
American Gene Technologies
(301) 337-2269
email us here


Source: EIN Presswire

Januarie Wood to be Featured on CUTV News Radio

SEATTLE, WASHINGTON, UNITED STATES, August 20, 2018 /EINPresswire.com/ — To live from a higher vibration means not only to live more authentically, but to follow your inner guidance and intuition completely. This creates an enticing life of joy and wonder where your highest self is invited to emerge!

Januarie Wood Is a HiVibe practitioner, clairvoyant, and international speaker. She offers individual mentoring programs, corporate trainings, classes and talks, Energy Readings, and MindMeditations.

“It's learning how to be embodied, authentic, fully present,” says Januarie. “It's time for us to connect to our core purpose of why we came into this earth and our core connection to one another.”

Januarie has appeared on ACB, NBC, FOX, and CBS news programs and has been featured in 417 Magazine, local Business Journals, Today’s Woman, and various publications for her work in stress management, weight release and related topics.

“Everything I offer is about raising your vibration and allowing you to express your soul's truest purpose,” explains Januarie. Clients are people from all walks of life who need a shift in their lives. They feel it, but they’re not sure what to do next.

Januarie’s has spoken for Wichita State University, Cal Poly University, Justice Jewelers, Los Angeles Circuit Courts, Kansas City School Board, Fort Belvoir, and various other companies in the States and internationally.

Individual clients come away with a deeper sense of purpose, more peace and clarity and much less stress. And they have a set of tools and exercises they can continue to use on their own.

Groups and teams come away with a sense of their own motivations and ways of operating and how to become more genuine and effective. They learn how to engage with others on a higher level and how to use their Intuitive Intelligence to create peace and flow in their organizations.

“The bigger picture is this: We must learn to trust our inner knowing and engage our brains less. This leads us to less stress and struggle and abundant joy and purpose. It’s time to surrender to a better way of operating – That’s HiVibe Living.”

CUTV News Radio will feature Januarie Wood in an interview with Doug Llewelyn on August 22nd at 1pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Januarie Wood, visit www.januarie.net

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Psychologist Dr. Valerie Kendall to be Featured on CUTV News Radio

CALGARY, ALBERTA, CANADA, August 20, 2018 /EINPresswire.com/ — Psychologist Valerie Kendall, or Dr. Val as she is familiarly known, is an MA, PhD, Registered Therapist with numerous other credentials in her arsenal. She also practices a full complement of modalities, and for clients of all ages. As a certified Play Therapist in both Canada and the U.S.A., she works a lot with children through the medium of play. With many adults she counsels in the field of ADD or addictive behaviors, which include sex addiction, gambling, and The Internet. Regarded as a Substance Abuse Expert, she assesses and counsels people on the abuse of alcohol and drugs. With other adults, she functions as a couples’ counselor. Above all, she is someone who cares, who builds a true relationship with clients and offers the kind of unconditional love that lets them know that even when they feel they are at the most unlovable point in their lives, they still have value.

Dr. Val practices out of two localities 1) The Healing Space, Calgary, and 2) McRae St. Okotoks. She is affiliated with many professional associations in Canada including: CPA, PAA, CCPA, CFCH, (AB.), ACEP. She’s registered and certified with the American Board of Hypnotherapy and the Alberta Hypnotherapy Association. Dr. Val attends workshops and conferences offered by the Rocky Mountain Play Therapy Institute, where she did most of her child therapy training. This led to an invitation to write a chapter in the forthcoming book Turning Points in Play Therapy and The Emergence of Self. Her section recounts one case history that professionals and families will learn from, about when a child in play therapy reveals that first glimmer of hope and progress.

While some of Dr. Val’s therapies correlate to energy and that might seem edgy, she felt that if so many PhDs were involved in an organization like ACEP (Association for Comprehensive Energy Psychology), it must be worth investigating. Depending on the client, their interest and mindset, she might use a newer technique like EFT or a more conventional approach like cognitive behavioral therapy When she does apply Emotional Freedom Technique, she’ll introduce the concept of energy flow and tell clients energy is something that exists, but we don’t see it travelling across the air – like the key fob that opens a car door or a cell phone text message. This energy is inside us too, and Dr. Val might tap on acupressure points in the body to release it and rebalance the body.

Dr. Val has lived in England and Canada and was in the education field before she became a therapist, as a resource room teacher and sports coach. She believes the one-to-one rapport she used with students is what helps her reach children today, and to create a sense of respect for people of any age. Being genuine, having positive regard, establishing trust, and empathy for the client are some elements of Carl Rogers’ person-centered approach that inspire congruence with patients. This Carl’s emphasis on the relationship revolutionized the American Psychological approach, which at the time emphasized psychodynamic and behaviorist method. It makes him one of Dr. Val’s idols. Another Carl that influenced her was Carl Jung. She embraces many of his concepts, such as archetypes (inborn tendencies resonating and driving basic human behavior), and his sense of connectedness across our big world– like when a butterfly flaps its wings in Japan and it is felt elsewhere.

Dr. Val says some techniques that work with children can also break through to adults. Someone might be nervous about opening up to a therapist, but when you toss them a ball, or hand them a musical instrument, it’s not formal or intimidating anymore. Still, she has to tell clients things they don’t want to hear, like own up to the consequences of an impulsive choice or negative behavior, or it’s to go off to rehab. She may have to be tough at times, but for the most part she likes to have fun, and loves bringing about change.

CUTV News will feature Dr. Valerie Kendall in an interview with Jim Masters on Wed, Aug 22 at 4:00pm EDT

Listen to the show on BlogTalkRadio

If you have questions for our guest, please call (347)996-3369

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

CVR MEDICAL REPORTS POSITIVE INTERIM RESULTS FROM ONGOING PIVOTAL TRIAL WITH CSS DEVICE

Preliminary Analysis Demonstrates CSS Device Has To Date Exceeded Expectations for Specificity and Sensitivity Compared to Duplex Doppler Ultrasound

CVR Medical Corp (TSX:CVM.V)

VANCOUVER, BRITISH COLUMBIA, CANADA, August 20, 2018 /EINPresswire.com/ — VANCOUVER, BC / August 20th, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector announces advisory staff member Dr. Phillip J. Bendick, PhD, has released an internal report summarizing data from the pivotal clinical trials for the Carotid Stenotic Scan (CSS) devices in use at Thomas Jefferson University Hospital. In alignment with the previous report released by Dr. Bendick in September 2017, this preliminary report views the initial batch of data points collected within the trial as successful for the substantiation of the device’s value and efficacy. Though only a partial snapshot of the data (with the trial ongoing), the improvements made to the CSS prior to launch of the pivotal clinical trials has generated enhanced functionality within the clinical setting.

The CSS Device is being evaluated in a multi-center pivotal clinical trial to evaluate the system’s specificity and sensitivity for detecting carotid artery disease, compared to the current gold standard – duplex Doppler ultrasound.

Dr. Bendick states, “The early results of the first 144 patients enrolled in the CSS pivotal trial have shown excellent overall accuracy […] these initial results demonstrate the efficacy of the CSS as a tool to detect and guide the appropriate management of clinically important carotid artery disease in order to reduce stroke risk.”

“This report further validates the advancements implemented by CVR prior to the launch of our pivotal trials,” said Peter Bakema, CVR CEO. “All along we have aimed to arm the clinician with a tool that is not only accurate, but seamlessly translates to improved care for his or her patients. Every aspect of the CSS, from the user interface to the streamlined cart, embodies this principle. This preliminary report reinforces our previously stated commitment to deliver a product with greater than 85% sensitivity level.”

Additionally, due to the current extended lead time for mandatory electrical safety testing, CVR has extended its anticipated CSS FDA submission target to October 2018.

Carotid Stenotic Scan Pivotal Trial Internal Data Analysis: Data Summary with Patient Edits*
By: Phillip J. Bendick, PhD

Location: Thomas Jefferson University Hospital
Primary Investigator: Dr. David Whellan

Number of Samples Evaluated (Vessels): N=255**
Right 129
Left 126

True Negative (<50%)
Right 110
Left 115
Total 225

True Positive (>50%)
Right 13
Left 6
Total 19

False Negative
Right 0
Left 2
Total 2

False Positive
Right 6
Left 3
Total 9

False Positive / Negative Causes
Incorrect Sensor Array Placement 4
Excessive Noise (Internal) 2
Hardware Error 3
Unknown 2
Total 11

Given These Results-
Specificity 225/236 96%
Sensitivity 19/21 90%
Overall Accuracy 244/255 96%

* Patient exclusions (33 vessels): Prior carotid endarterectomy, prior carotid stent, prior neck surgery, severe heart disease.
** Vessels with No Reading (NR) or poor Quality of Placement (QOP) – 38 (Most of these were on Device 7)

CAUTION: FOR INVESTIGATIONAL USE ONLY. This device is not yet cleared or approved for use in humans by the Food and Drug Administration.

About CVR Medical

CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary CSS Device. The CSS device is a diagnostic tool that encompasses subsonic, infrasonic, and low frequency sound wave analysis technology. The CSS Device is a patented device designed to detect and measure carotid arterial stenosis. CVR is currently in pivotal clinical trials in preparation for its planned submission to the FDA. CVR is led by an experienced and proven team of professionals with extensive healthcare, medical device, international expansion, regulatory and sales experience. CVR Medical trades on the TSX Venture Exchange under the symbol CVM. Additional information regarding the Company can be found in our recent filings with the SEDAR as well as the information maintained on our website at www.cvrmed.com

ON BEHALF OF THE BOARD:
(signed) "Peter Bakema"
CEO, President & Director

For further information contact:
Peter Bakema, CEO, President and Director
Email: info@cvrmed.com
or
Marc S. Lubow.
Vice President Capital Markets, Investor Relations
marclubow@cvrmed.com

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Peter Bakema
CVR Medical Corp.
734-718-5115
email us here


Source: EIN Presswire

Alyson Franz of Paradigm Shift to be Featured on CUTV News Radio

JOHNSTON, RHODE ISLAND, UNITED STATES, August 20, 2018 /EINPresswire.com/ — While traditional talk therapy is considered the standard in mental healthcare, rarely does it lead to people completely letting go of their problems. In fact, people will often rehearse their problems instead of letting them go if all they do is talk about them.

Alyson Franz is a bilingual licensed independent clinical social worker and the founder of Paradigm Shift, where she offers transformational healing programs, coaching and therapy, as well as personal growth workshops and programs.

“Paradigm Shift is about transformation,” says Alyson. “It's about being able to let go of whatever is holding you back and stepping into the best version of yourself.”

Alyson specializes in synergetic therapy, a combination of traditional therapies and modern therapy modalities, which includes energy psychology, mindfulness and spirituality.

“We integrate a lot of energy psychology into the traditional healing model because energy psychology actually gets to the root of the problem,” says Alyson. “Everything is energy at its core, including emotions, whatever block or fear or issue that we're having is energetic at its core. We identify what it is, that's affecting the person, whether it be a trauma, a belief, an identity, or fear. There's lots of possibilities of energetically what could be holding people back. We're good at figuring out what that block is and helping them release it.”

According to Alyson, the whole premise of energy psychology is that a disruption in our energy system is the root cause of whatever symptoms we're experiencing: sadness, depression, anxiety and nightmares are just some examples. That energetic charge is what we need to clear.

“I don't just want to be a good therapist, I want to help people tap into their unlimited potential, because we all have this potential, but very few of us use it. Once you start letting go of your blocks life can become amazing. I’ve seen people make unbelievable changes in their lives.”

Many people have experienced trauma or other life events that led them to feeling stuck, unhappy and unfulfilled. Alyson was that person. She knew that life was meant to be happy and there was a way she could completely heal, but she had no idea what it would take.

“Synergetic therapy was a big part of my healing process,” says Alyson. “I feel like I've been very thorough on the work on myself, so it's very easy for me to help people get insight into what's going on for them. And after we identify the block we clear it from their system. And we all have a lot more blocks than we think we do. People are frequently surprised by how many blocks they actually have.!”

As for the future, Alyson plans to expand Paradigm Shift’s model and serve as a light for the community and help clients awaken to their full potential.

CUTV News Radio will feature Alyson Franz in an interview with Doug Llewelyn on August 22nd at 12pm EDT and with Jim Masters on August 29th at 12pm EDT.

Listen to the show on BlogTalkRadio. If you have a question for our guest, call (347) 996-3389.

For more information on Paradigm Shift, visit www.paradigmshiftri.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Global Neuroprosthetics Market Research and Forecast 2018-2023

Global Neuroprosthetics Industry Research Report

Orion market Research | OMR Global

Global Neuroprosthetics Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Rising prevalence of neural diseases is the major driver for the growth of neuroprosthetics market.”

— OMR Analyst

INDORE, INDIA, August 17, 2018 /EINPresswire.com/ — According to OMR analysis, the global neuroprosthetics market is expected to grow at a significant rate during (2018-2023). The global neuroprosthetics market has been showing significant growth due to increasing prevalence of neural diseases and rising inclination towards spinal cord injury treatment. The global neuroprosthetics market is segmented on the basis type, treatment technique, application and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market share analysis, competitive landscape, company profiling, market segmentation, geographical analysis, analyst insights.

Full report of global neuroprosthetics market is available at: https://www.omrglobal.com/industry-reports/neuroprosthetics-market/

“The global neuroprosthetics market on the basis of treatment technique is bifurcated as deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS) and spinal cord stimulation (SCS). DBS as a treatment has been approved by the FDA in 1997 for essential tremor and Parkinson's disease; in 2003 for dystonia; and for OCD in 2009. DBS system is being used in research studies for the treatment of chronic pain, Post-Traumatic Stress Disorder (PTSD). It has also been used for the treatment of various affective disorders such as major depression. DBS is a neurosurgical process that involves implantation of a medical device, neurostimulator or sometimes called brain pacemaker. This device sends electrical impulses to specific targets in the brain through implanted electrodes for treating the movement and neuropsychiatric disorders.”

The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is considered to be dominating market. The market is expected to grow at a stable CAGR. North American market is driven by high prevalence of spinal cord injuries, ability of people to afford the expensive treatment and research and development in artificial senses. Asia Pacific market is expected to have the highest CAGR amongst all regions for the forecast period of 2018-2023. APAC market is driven by increasing disposable income and improved healthcare facilities in the Asian countries.

The report covers:
· Comprehensive research methodology of Neuroprosthetics Market
· This report also includes detailed and extensive market overview with key analyst insights.
· An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
· Analysis of regional regulations and other government policies impacting the Neuroprosthetics Market
· Insights about market determinants which are stimulating the Neuroprosthetics Market
· Detailed and extensive market segments with regional distribution of forecasted revenues.
· Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/medical-devices/

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Global Neuroprosthetics Market Report


Source: EIN Presswire

Global Minimally Invasive Surgical Instruments Market Research and Forecast 2018-2023

Minimally Invasive Surgical Instruments Market

Global Industry Research By OMR

Global Minimally Invasive Surgical Instruments Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Rising prevalence of lifestyle-oriented diseases & technological innovations is fuelling minimally invasive surgical instruments market.”

— OMR Analyst

INDORE, INDIA, August 17, 2018 /EINPresswire.com/ — According to OMR analysis the global minimally invasive surgical instruments market is growing significantly during the forecast period 2018-2023. The global minimally invasive surgical instruments market has been segmented on the basis of product, technology and applications. The report provides detailed & insightful chapters which includes market overview, key findings, strategic recommendations, market estimations, device regulations, market determinants, key company analysis, market insights, company profiling, market segmentation, and geographical analysis.

Increasing prevalence of lifestyle oriented diseases such as CVD is driving the demand for minimally invasive surgical instruments market. According to WHO, CVD is the major cause of death globally and more people lost their lives due to CVD than any other cause. CVD has accounted around 17.7 million deaths in 2015. It represents 31% of all global deaths. Among these deaths, 7.4 million were occurred due to heart disease and 6.7 million due to stroke. More than three quarters of CVD deaths witnessed in low and middle income countries. Such prevalence of CVD leads the demand for minimally invasive surgical instruments for the treatment of patients with CVD. The advantage of minimally invasive cardiac surgery is extensive than the open-heart surgery. Open heart surgery requires 6-8 incision in the chest and might be needed temporary placement of a pacemaker to regulate patient’s heartbeat.

Full report of Global Minimally Invasive Surgical Instruments Market is available at: https://www.omrglobal.com/industry-reports/minimally-invasive-surgical-instruments-market/

However, the minimally invasive cardiac surgery can be performed using robotic and involves one or more tiny incisions between ribs. Thereafter, surgical instruments coupled with small camera are placed through the incision. Then, the surgical tools are linked to the arms of robotics that is controlled by the surgeon with a computerized device. The instruments used in minimally invasive cardiac surgery include retractors, forceps, cutter instruments, stents and sutures. Additionally, minimally invasive cardiac surgery methods are used in atrial septal defect closure, aortic valve replacement, mitral valve repair and maze procedures to treat atrial fibrillation. There are several benefits associated with minimally invasive cardiac surgery as smaller incisions are involved in it. Moreover, it includes shorter hospital stays (generally 2-5 days), minimal risk of bleeding and infection, less scarring and pain and shorter recovery time.

The global minimally invasive surgical instruments market is segmented into product, technology and applications. Based on technology, robotic-assisted methods are gaining significant popularity and technological innovations have been observed which is increasing the effectiveness of this technology. Robot-assisted methods are used in several specialties, including head and neck surgery, urology, gynecologic oncology, cardiothoracic and gastrointestinal. For example, In Dec 2016, Cambridge consultants developed Axsis robot to overcome challenges of current surgical robots, including the inability to act with extremely fragile and detailed tissues and large size of the robots. Like da Vinci surgical systems, Axsis doesn’t use rigid and long instruments, however, rely on flexible components results in the smaller size of the robot. Axsis is designed to perform cataract surgery. It has flexible, tiny and worm-like arms and controlled with a joystick that offers tactile feedback. Additionally, it has an internal algorithm autopilot that keeps the surgeons who are guiding it to not make dumb mistakes. The system assimilates with real-time 3D imaging that provides an advanced level of robotic assistance. Posterior Capsule (PC) tears are the most common serious complications in the UK. Axsis can reduce complications rates and develop patient outcomes.

The report covers:
Comprehensive research methodology of Global MIS Instruments Market.
This report also includes detailed and extensive market overview with Analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global MIS Instruments Market.
Insights about market determinants which are stimulating the Global MIS Instruments Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/medical-devices/

About orion market research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Global Minimally Invasive Surgical Instruments Market Research Report


Source: EIN Presswire

Luxury Tour Provider Announces Private Scuba Diving Onboard Exclusive Catamaran Yacht

Luxury yacht charter in Cabo San Lucas

Scuba diving in Cabo San Lucas

Have a Magical Experience Onboard a Luxury Yacht and Explore the Depths of the Sea of Cortez with Private Scuba Diving Tours!

Life is a journey with problems to solve, lessons to learn, but most of all, Experiences to enjoy”

— unknown

CABO SAN LUCAS, BAJA CALIFORNIA SUR, MEXICO, August 16, 2018 /EINPresswire.com/ — FOR IMMEDIATE RELEASE: Operator of the highest rated luxury cruises is now offering voyages aboard luxury catamaran yachts along with a private luxury scuba diving experience. The luxury scuba diving holiday provider has announced they are now also offering private luxury scuba diving onboard a luxury catamaran yacht with state-of-the-art facilities and impeccable services.
At a recent launch event, the spokesperson for the company said, CABO YACHT WORLD is proud to announce that we have recently added a new yacht to our scuba diving excursions. We are extremely excited to have included a luxury Catamaran yacht ARISE to our fleet specially because we have a dive master on board that has been certified even for handicapped guests, and the addition of the new luxury Catamaran yacht is sure to add to the amazing experience.”
The Catamaran is a multi-hulled watercraft that features state-of-the-art facilities such as, two parallel hulls. That Catamaran is a geometry-stabilized craft, and derives its stability from its extra wide beam, rather than a monohull sailboat which has a ballasted keel. Thus, it offers complete comfort while sailing and scuba diving.
On answering a question, the spokesperson stated, “We are very happy with the inclusion of the new catamaran yacht to our scuba diving tour. The Catamaran offers the best in comfort and luxury, with spacious cabins, en-suite facilities and a sprawling deck along with salon areas.You can rest assured that our 64 ft. Catamarans have all amenities and equipment one would look for uninterrupted dives, making it the perfect vessel for exploring remote areas where underwater treasures are waiting to be explored in the sea of Cortez.”
The MY 64ft (19.51m) Lagoon Catamaran Yacht will be sailing to the relatively untouched Sea of Cortez, also known as the ‘Gulf of California’ which is considered to be one of the hot spots for biodiversity and marine life, along with a flourishing coral reef that’s just waiting to be explored. The sea is wedged between Baja California and the mainland Mexico with a sheltered and narrow outline, which results to mostly calm waters, making it an ideal spot for the best scuba diving experience possible.
He concluded by saying, “Our luxury scuba diving tour onboard a luxury catamaran yacht is perfect for people who love the sea. the Sea of Cortez is an amazing place to visit. The warm waters are relatively calm, with high mountains in a distance rise from the bluish-green sea and upwards to the blue sky. It is the perfect place to spend a full day with friends or family. Once below the water, you are freed from gravity, and experience absolute freedom. Guests on our luxury scuba diving tours will get to spot up to 900 different fish species. Gently touch them, sit on the ocean’s floor, or play with the sand, and feel like a true National Geographic explorer of the deep sea. The boat ride to and from the dive site is also a sight to behold, not only because of the amazing natural beauty of the surroundings but because Grey whales and Humpback are often spotted en route, which makes the experience magical.In short, it’s a great body of water to explore, and we’d love it if you would join us for this unforgettable adventure.”
Private luxury scuba diving onboard a luxury Catamaran yacht along with other tours are available for pre-booking by calling [01 52 624 168 9544] or emailing us at [caboyachtworld@gmail.com]. Guests of our Luxury Catamaran Yacht and diving experience can also arrange for private tours and excursions that are customized according to their needs and travel budgets.

About Us:
Cabo Yacht World operates award-winning luxury Catamaran yachts and cruising luxury yachts, which provide exceptional cruising experiences to its guests. All tours can be tailored to specific needs of tourists to provide an unparalleled experience at the most enchanting destinations. The tour company is committed to delivering a high level of quality with their private and group tour packages.
Contact Information
Cabo Yacht World
Boulevard marina s/n lte E1B Col. Centro Cabo San Lucas BCS 23450
01 52 624 157 1136
caboyachtworld@gmail.com
https://www.caboyachtworld.com/63-foot-lagoon-catamaran/

Arturo Chacon
Cabo Yacht World
6241689544
email us here

64 foot Lagoon luxury yacht charter in Cabo San Lucas


Source: EIN Presswire

The Boy Scouts Dive in to a Different Dimension With The L. Ron Hubbard East Coast Theatre

L. Ron Hubbard East Coast Theatre actors perform a final rehearsal of the classic Science Fiction story “The Dangerous Dimension” at the Clearwater Community Volunteers Center in downtown Clearwater. In the audience were the Boy Scouts of Troop 313

L. Ron Hubbard's East Coast Golden Age Theatre opens rehearsal to the public for the first time at the Clearwater Community Volunteers Center in downtown

CLEARWATER, FLORIDA, USA, August 16, 2018 /EINPresswire.com/ — On Tuesday August 14, the Clearwater Community Volunteers Center, opened and supported by the Church of Scientology Flag Service Organization, hosted the L. Ron Hubbard East Coast Theatre in their final rehearsals of their upcoming presentation of L. Ron Hubbard’s pulp fiction story The Dangerous Dimension. The rehearsal served as an exclusive behind the scenes preview for Boy Scout Troop 313 before the Theater’s live performance on August 18 in the Scientology Information Center, located on the corner of Cleveland Street and Fort Harrison Ave.

This is the first time the Theatre allowed a group to see their rehearsal. The Boy Scouts saw how the theater polishes each final performance using costumes and sound effects.

“These actors practice every week to create a stellar performance that will bring people in the community together,” said Michael Soltero, Manager of the Center. “By opening their rehearsals to the Boy Scouts they accomplish what the Center was established for: bringing different community groups together. They’re doing as humanitarian L. Ron Hubbard wrote, ‘A community that pulls together can make a better society for all.”

The Dangerous Dimension by L. Ron Hubbard is based on Dr. Henry Mudge, who discovers the mathematical formula “Equation C”, which outlines a negative dimension. Using this equation, Dr. Mudge is instantly transported to any location in the solar system by simply thinking of it.

For more information about the Clearwater Community Volunteers Center or to attend an upcoming event, please call Michael Soltero at (727) 316-5309 or email ccvcenter@ccvfl.org.

About the Clearwater Community Volunteers:

The Clearwater Community Volunteers (CCV) have over 25 years of community service under their belt with over 150,000 families and children helped since their founding in 1992. CCV stays true to their reputation of helping others with their new center, located on the corner of Fort Harrison Ave. and Drew St. in downtown Clearwater, which facilitates the growth of non-profits by serving as a free event venue & meeting space. CCV and the CCV Center are sponsored by the Church of Scientology Flag Service Organization.

Pat Harney
Church of Scientology Flag Service Organization
727-467-6860
email us here


Source: EIN Presswire

Global Pharmacy Benefit Management Market (PBM) 2018 Analysis and Forecast to 2023 Research Report

MarketResearchNest.com adds “Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers Regions Type and Application to 2023” report to its database.

PUNE, INDIA, August 16, 2018 /EINPresswire.com/ — MarketResearchNest.com adds “Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” new reports to its research database. The report spread across 133 pages with tables and figures in it.

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

This report focuses on the Pharmacy Benefit Management (PBM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pharmacy Benefit Management (PBM) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Order a purchase report copy of at https://www.marketresearchnest.com/report/purchase/403080 .

Market Segment by Manufacturers, this report covers
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquire before Buying at https://www.marketresearchnest.com/report/enquirybuy/403080 .

Market Segment by Type, covers
commercial health plans
self-insured employer plans
Medicare Part D plans
Federal Employees Health Benefits Program
state government employee plans

Market Segment by Applications, can be divided into
Mail-order Pharmacy Services
Non-mail Pharmacy Services

There are 15 Chapters to deeply display the global Pharmacy Benefit Management (PBM) market.
Chapter 1, to describe Pharmacy Benefit Management (PBM) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pharmacy Benefit Management (PBM), with sales, revenue, and price of Pharmacy Benefit Management (PBM), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmacy Benefit Management (PBM), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pharmacy Benefit Management (PBM) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pharmacy Benefit Management (PBM) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Get a Report Details at https://www.marketresearchnest.com/Global-Pharmacy-Benefit-Management-PBM-Market-2018-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2023.html .

About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Contact Us
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070 / +44-20-3290-4151

Mr Jeet
Market Research Nest
1-240-284-8070
email us here


Source: EIN Presswire